在不安腿综合征的血清α-synuclein
Aboud Tahanis1, Vera Hashem2, William Ondo2,3
1Department of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, Houston, TX, USA.
Sleep
|September 16, 2024
概括
血清alpha-synuclein (α-syn) 在不安腿综合征 (RLS) 患者中较低. 静脉输入铁补充剂增加了α-syn水平,这表明RLS中多巴胺传播的潜在机制.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 临床医学 临床医学
背景情况:
- 不安腿综合征 (RLS) 是一种神经疾病,其特点是迫切需要移动腿部.
- RLS的病理生理学尚未完全理解,但涉及多巴胺功能障碍.
- 阿尔法-同核素 (α-syn) 是一种参与神经元功能和神经退行性疾病的蛋白质.
研究的目的:
- 调查血清α-synuclein (α-syn) 度与不安腿综合征 (RLS) 之间的相关性.
- 评估静脉 (IV) 铁补充剂对RSS患者血清α-syn水平的影响.
主要方法:
- 用ELISA测量了113名RLS患者和45名年龄匹配对照的血清α-syn水平.
- 九名RLS患者的小组接受了静脉铁,并采集了治疗前和治疗后的血液样本.
- 此外,还评估了血清费里丁水平.
主要成果:
- 与对照组 (10.7 ng/mL) 相比,RLS患者的血清α-syn水平显著降低 (7.7 ng/mL).
- 在39.8%的RLS患者中观察到低血清费里丁 (<75μg/L).
- 在接受静脉铁治疗的患者中,观察到α-syn和费里丁折叠变化之间的正相关性 (R=0.7,p<0.05).
- 在IV铁治疗后观察到α-syn和ferritin的显著时间下降 (p=0.023,R=-.739).
结论:
- 血清α-syn水平在RLS患者下降,与健康个体相比.
- 在RSS患者的IV铁治疗与血清α-syn水平和ferritin的增加相关.
- 观察到的相关性表明,在RLS病理生理学中,铁含量,α-syn和多巴胺转移之间存在潜在的联系.
更多相关视频
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
17.3K
相关概念视频
Restless Leg Syndrome and Night Terrors
155
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
155
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
REM Sleep Behavior Disorder
162
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
162
Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498
Parkinson's Disease: Treatment
237
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
237
